Severe pancytopenia associated with the use of intravesical thio-TEPA.
作者信息
Watkins W E, Kozak J A, Flanagan M J
出版信息
J Urol. 1967 Oct;98(4):470-1. doi: 10.1016/S0022-5347(17)62912-4.
PMID:4964489
Abstract
摘要
相似文献
1
Severe pancytopenia associated with the use of intravesical thio-TEPA.与膀胱内使用噻替派相关的严重全血细胞减少症。
J Urol. 1967 Oct;98(4):470-1. doi: 10.1016/S0022-5347(17)62912-4.
2
Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.膀胱癌症用三乙烯硫代磷酰胺灌注治疗后出现全血细胞减少和全身性败血症。
J Urol. 1967 Mar;97(3):482-5. doi: 10.1016/S0022-5347(17)63063-5.
3
[Fatal bone marrow aplasia due to endovesical thio-tepa].
J Urol Nephrol (Paris). 1973 Dec;79(12 Pt 2):489-91.
4
Renal failure associated with the use of thio-tepa.与使用硫替派相关的肾衰竭。
J Urol. 1973 Nov;110(5):498-501. doi: 10.1016/s0022-5347(17)60262-3.
5
Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.膀胱内注射噻替派治疗移行细胞膀胱癌。
Br J Urol. 1971 Apr;43(2):185-8. doi: 10.1111/j.1464-410x.1971.tb12024.x.
6
The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
J Urol. 1966 Dec;96(6):913-8. doi: 10.1016/S0022-5347(17)63381-0.
7
The effect of intravesical thio-tepa on normal and tumor urothelium.
J Urol. 1978 Jan;119(1):59-61. doi: 10.1016/s0022-5347(17)57383-8.
8
Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.膀胱内注射噻替哌用于复发性膀胱移行细胞癌患者术后即刻阶段。
J Urol. 1978 Oct;120(4):410-1. doi: 10.1016/s0022-5347(17)57202-x.
9
The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.硫替派和尿激酶在膀胱移行细胞癌中的预防性应用：初步报告。
J Urol. 1975 Sep;114(3):394-8. doi: 10.1016/s0022-5347(17)67038-1.
10
[Dibunol and thio-TEPA treatment of bladder tumors].
Urol Nefrol (Mosk). 1978 Jul-Aug(4):27-30.
引用本文的文献
1
The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer.非肌层浸润性膀胱癌膀胱内药物递送的未来
Bladder Cancer. 2016 Jul 27;2(3):285-292. doi: 10.3233/BLC-160056.
2
Bladder hyperthermia in the treatment of vesical papillomatosis.
Int Urol Nephrol. 1973 Jan;5(1):75-84. doi: 10.1007/BF02081753.
3
Absorption of drugs from the bladder and intravesical chemotherapy.药物从膀胱的吸收及膀胱内化疗
Urol Res. 1976 Apr 21;4(1):1-3. doi: 10.1007/BF00256127.
4
Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.硫替派局部应用预防膀胱乳头状癌复发
Int Urol Nephrol. 1979;11(1):39-44. doi: 10.1007/BF02082809.
Zotero 插件